News
Further analysis of the results from a recent clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's has revealed encouraging signs of a positive effect on mood.
The trial will test whether drug treatment with a commonly prescribed dementia drug can improve balance and walking and help to prevent falls in people with Parkinson's.
New research shows that scrapping prescription charges for Parkinson's and inflammatory bowel disease could save the NHS money.
Key information about the recent recall of neurology patients in Northern Ireland.
We are pleased to announce that a Parkinson's research project has been awarded the inaugural BenevolentAI Award. The project will use an artificial intelligence platform’s capabilities to reason, deduce and suggest entirely new treatments for Parkinson’s.
Celebrities, Trustees and people with Parkinson's attended a St James's Palace reception on Tuesday to celebrate Jane Asher’s anniversary as our President.
An international team has developed a cutting-edge technique, enabling human brain tissue to be studied in 3D.
New international research suggests that too much calcium inside brain cells may trigger a chain reaction that leads to Parkinson's.
We're partnering with US company Neurolixis to accelerate the development of a drug that could prevent dyskinesia, a debilitating side effect of Parkinson's medication.
A study, featured in the Daily Mail, suggests a link between certain types of flu and risk of Parkinson's.